Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

189 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Shaping the future of pharmacoepidemiology in France: Recommendations from the SFPT Pharmacoepidemiology Working Group.
Soeiro T, Allouchery M, Bene J, Bezin J, Dolladille C, Faillie JL, Grimaldi L, Kaguelidou F, Khouri C, Lafaurie M, Largeau B, Montastruc F, Morin L, Scailteux LM, Pariente A; SFPT Pharmacoepidemiology Working Group. Soeiro T, et al. Among authors: lafaurie m. Therapie. 2024 Dec 14:S0040-5957(24)00213-0. doi: 10.1016/j.therap.2024.12.005. Online ahead of print. Therapie. 2024. PMID: 39706774 Review.
[Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice].
de Germay S, Conte C, Micallef J, Bouquet E, Chouchana L, Lafaurie M, Pariente A; au nom du groupe de pharmaco-épidémiologie de la Société Française de Pharmacologie et de Thérapeutique (SFPT). de Germay S, et al. Among authors: lafaurie m. Therapie. 2023 Nov-Dec;78(6):691-703. doi: 10.1016/j.therap.2023.01.010. Epub 2023 Jan 29. Therapie. 2023. PMID: 36841652 French.
Performing pharmacoepidemiological studies using the French health insurance data warehouse (SNDS): How to translate guidelines into practice.
de Germay S, Conte C, Micallef J, Bouquet E, Chouchana L, Lafaurie M, Pariente A; Pharmacoepidemiological group of the French Society of Pharmacology and Therapeutics (SFPT). de Germay S, et al. Among authors: lafaurie m. Therapie. 2023 Nov-Dec;78(6):679-689. doi: 10.1016/j.therap.2023.01.009. Epub 2023 Jan 28. Therapie. 2023. PMID: 36841656
Infectious risk when prescribing rituximab in patients with hypogammaglobulinemia acquired in the setting of autoimmune diseases.
Boumaza X, Lafaurie M, Treiner E, Walter O, Pugnet G, Martin-Blondel G, Biotti D, Ciron J, Constantin A, Tauber M, Puisset F, Moulis G, Alric L, Renaudineau Y, Chauveau D, Sailler L. Boumaza X, et al. Among authors: lafaurie m. Int Immunopharmacol. 2023 Jul;120:110342. doi: 10.1016/j.intimp.2023.110342. Epub 2023 Jun 3. Int Immunopharmacol. 2023. PMID: 37276827
IgA Vasculitis Following COVID-19 Vaccination: A French Multicenter Case Series Including 12 Patients.
Ramdani Y, Bettuzzi T, Bouznad A, Delaitre L, Nassarmadji K, Didier K, Paul C, Liozon E, Tieu A, Richard-Colmant G, Terrier B, Moulis G, Lafaurie M, Pillebout E, Maillot F, Audemard-Verger A. Ramdani Y, et al. Among authors: lafaurie m. J Rheumatol. 2023 Feb;50(2):252-257. doi: 10.3899/jrheum.220545. Epub 2022 Nov 1. J Rheumatol. 2023. PMID: 36319000 Free article.
189 results